Abstract
The neurotransmitter γ-aminobutyric acid (GABA) is involved in the process of memory. It has been reported that the inhibition of GABAB receptors has beneficial effects on cognition. The aim of this study was to investigate the role of CGP35348 (a GABAB receptor antagonist) on dentate gyrus GABAB receptor inhibition and its effects on learning and memory impairments that had been induced in adult male rats by microinjection of β-amyloid (Aβ). Seventy Wistar male rats were randomly divided into seven groups: control, sham (receiving the Aβ vehicle only), Aβ, Aβ + CGP35348 (1, 10, and 100 μg/μL), and CGP35348 alone (10 μg/μL). Memory impairment was induced by unilateral interventricular microinjection of Aβ (6 μg/6 μL). Rats were cannulated bilaterally in the dentate gyrus, and then, they were treated for 20 consecutive days. Learning and memory were assessed using the novel object recognition and passive avoidance learning tests. The discrimination index and the step-through latency were significantly increased in the Aβ + CGP35348 group in comparison to the Aβ only group (P < 0.05 and P < 0.01, respectively). Data showed that the discrimination index was decreased in the Aβ + CGP35348 group in comparison with the control group (P < 0.05) and sham group (P < 0.01). Moreover, the step-through latency was significantly decreased in the Aβ + CGP35348 group in comparison to the control and sham groups (P < 0.01). Data from this study indicated that intra-hippocampal microinjection of the GABAB receptor antagonist counteracts the learning, memory, and cognitive impairments induced by Aβ. It can be concluded that the GABAB receptor antagonist is a possible therapeutic agent against the progression of acute Aβ toxicity-induced memory impairment.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alvarez-Ruiz Y, Carrillo-Mora P (2013) Amyloid beta 25-35 impairs reconsolidation of object recognition memory in rats and this effect is prevented by lithium carbonate. Neurosci Lett 548:79–83. https://doi.org/10.1016/j.neulet.2013.06.003
Andre P, Ferrat T, Steinman M, Olpe HR (1992) Increased acetylcholine and quisqualate responsiveness after blockade of GABAB receptors. Eur J Pharmacol 218(1):137–143
Arbel-Ornath M, Hudry E, Boivin JR, Hashimoto T, Takeda S, Kuchibhotla KV, Hou S, Lattarulo CR, Belcher AM, Shakerdge N, Trujillo PB, Muzikansky A, Betensky RA, Hyman BT, Bacskai BJ (2017) Soluble oligomeric amyloid-beta induces calcium dyshomeostasis that precedes synapse loss in the living mouse brain. Mol Neurodegener 12(1):27. https://doi.org/10.1186/s13024-017-0169-9
Avila J, Llorens-Martin M, Pallas-Bazarra N, Bolos M, Perea JR, Rodriguez-Matellan A, Hernandez F (2017) Cognitive decline in neuronal aging and Alzheimer's disease: role of NMDA receptors and associated proteins. Front Neurosci 11:626. https://doi.org/10.3389/fnins.2017.00626
Barzegar S, Komaki A, Shahidi S, Sarihi A, Mirazi N, Salehi I (2015) Effects of cannabinoid and glutamate receptor antagonists and their interactions on learning and memory in male rats. Pharmacol Biochem Behav 131:87–90. https://doi.org/10.1016/j.pbb.2015.02.005
Bowery NG, Smart TG (2006) GABA and glycine as neurotransmitters: a brief history. Br J Pharmacol 147(Suppl 1):S109–S119. https://doi.org/10.1038/sj.bjp.0706443
Canas PM, Simoes AP, Rodrigues RJ, Cunha RA (2014) Predominant loss of glutamatergic terminal markers in a beta-amyloid peptide model of Alzheimer's disease. Neuropharmacology 76(Pt A):51–56. https://doi.org/10.1016/j.neuropharm.2013.08.026
Chu DC, Penney JB Jr, Young AB (1987a) Cortical GABAB and GABAA receptors in Alzheimer's disease: a quantitative autoradiographic study. Neurology 37(9):1454–1459
Chu DC, Penney JB Jr, Young AB (1987b) Quantitative autoradiography of hippocampal GABAB and GABAA receptor changes in Alzheimer's disease. Neurosci Lett 82(3):246–252
Colom LV, Castaneda MT, Hernandez S, Perry G, Jaime S, Touhami A (2011) Intrahippocampal amyloid-beta (1-40) injections injure medial septal neurons in rats. Curr Alzheimer Res 8(8):832–840
Das UN (2003) Can memory be improved? A discussion on the role of ras, GABA, acetylcholine, NO, insulin, TNF-alpha, and long-chain polyunsaturated fatty acids in memory formation and consolidation. Brain and Development 25(4):251–261
Deibel SH, Weishaupt N, Regis AM, Hong NS, Keeley RJ, Balog RJ, Bye CM, Himmler SM, Whitehead SN, McDonald RJ (2016) Subtle learning and memory impairment in an idiopathic rat model of Alzheimer's disease utilizing cholinergic depletions and beta-amyloid. Brain Res 1646:12–24. https://doi.org/10.1016/j.brainres.2016.05.033
Felice D, O'Leary OF, Pizzo RC, Cryan JF (2012) Blockade of the GABA(B) receptor increases neurogenesis in the ventral but not dorsal adult hippocampus: relevance to antidepressant action. Neuropharmacology 63(8):1380–1388. https://doi.org/10.1016/j.neuropharm.2012.06.066
Fgaier H, Mustafa IH, Awad AA, Elkamel A (2015) Modeling the interaction between beta-amyloid aggregates and choline acetyltransferase activity and its relation with cholinergic dysfunction through two-enzyme/two-compartment model. Computational and mathematical methods in medicine 2015(923762):1–20. https://doi.org/10.1155/2015/923762
Getova D, Bowery NG, Spassov V (1997) Effects of GABAB receptor antagonists on learning and memory retention in a rat model of absence epilepsy. Eur J Pharmacol 320(1):9–13
Ghahremanitamadon F, Shahidi S, Zargooshnia S, Nikkhah A, Ranjbar A, Soleimani Asl S (2014) Protective effects of Borago officinalis extract on amyloid beta-peptide(25-35)-induced memory impairment in male rats: a behavioral study. Biomed Res Int 2014(798535):1–8. https://doi.org/10.1155/2014/798535
Giachino C, Barz M, Tchorz JS, Tome M, Gassmann M, Bischofberger J, Bettler B, Taylor V (2014) GABA suppresses neurogenesis in the adult hippocampus through GABAB receptors. Development (Cambridge, England) 141(1):83–90. https://doi.org/10.1242/dev.102608
Giacobini E (1990) The cholinergic system in Alzheimer disease. Prog Brain Res 84:321–332
Gillani Q, Ali M, Iqbal F (2014) CGP 35348, GABA B receptor antagonist, has a potential to improve neuromuscular coordination and spatial learning in albino mouse following neonatal brain damage. Biomed Res Int 2014:–29e5215, 7. https://doi.org/10.1155/2014/295215
Gold CA, Budson AE (2008) Memory loss in Alzheimer's disease: implications for development of therapeutics. Expert Rev Neurother 8(12):1879–1891. https://doi.org/10.1586/14737175.8.12.1879
Goldsworthy MR, Vallence AM (2013) The role of beta-amyloid in alzheimer's disease-related neurodegeneration. J Neurosci 33(32):12910–12911. https://doi.org/10.1523/jneurosci.2252-13.2013
Hahm ET, Seo JW, Hur J, Cho YW (2010) Modulation of presynaptic GABA release by oxidative stress in mechanically-isolated rat cerebral cortical neurons. The Korean journal of physiology & pharmacology : official journal of the Korean physiological society and the korean society of pharmacology 14(3):127–132. https://doi.org/10.4196/kjpp.2010.14.3.127
Hardy J, Cowburn R, Barton A, Reynolds G, Lofdahl E, O'Carroll AM, Wester P, Winblad B (1987) Region-specific loss of glutamate innervation in Alzheimer's disease. Neurosci Lett 73(1):77–80
Harkany T, Abraham I, Timmerman W, Laskay G, Toth B, Sasvari M, Konya C, Sebens JB, Korf J, Nyakas C, Zarandi M, Soos K, Penke B, Luiten PG (2000) Beta-amyloid neurotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalis. Eur J Neurosci 12(8):2735–2745
Hasanein P, Shahidi S (2012) Preventive effect of Teucrium polium on learning and memory deficits in diabetic rats. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research 18(1):Br41–Br46
Hashemi-Firouzi N, Shahidi S (2018) 5-Hydroxytryptamine receptor 6 antagonist, SB258585 exerts neuroprotection in a rat model of Streptozotocin-induced Alzheimer's disease. https://doi.org/10.1007/s11011-018-0228-0
Hashemi-Firouzi N, Akhavan M, Komaki A, Shahidi S (2015) Effects of acute administration of Urtica dioica on the novel object-recognition task in mice. Avicenna J Neuro Psych Physio 2(3):e34150. https://doi.org/10.17795/ajnpp-34150
Heaney CF, Kinney JW (2016) Role of GABA(B) receptors in learning and memory and neurological disorders. Neurosci Biobehav Rev 63:1–28. https://doi.org/10.1016/j.neubiorev.2016.01.007
Helm KA, Haberman RP, Dean SL, Hoyt EC, Melcher T, Lund PK, Gallagher M (2005) GABAB receptor antagonist SGS742 improves spatial memory and reduces protein binding to the cAMP response element (CRE) in the hippocampus. Neuropharmacology 48(7):956–964. https://doi.org/10.1016/j.neuropharm.2005.01.019
Hernandez-Rabaza V, Cabrera-Pastor A, Taoro-Gonzalez L, Malaguarnera M, Agusti A, Llansola M, Felipo V (2016) Hyperammonemia induces glial activation, neuroinflammation and alters neurotransmitter receptors in hippocampus, impairing spatial learning: reversal by sulforaphane. J Neuroinflammation 13:41. https://doi.org/10.1186/s12974-016-0505-y
Honea RA, Thomas GP, Harsha A, Anderson HS, Donnelly JE, Brooks WM, Burns JM (2009) Cardiorespiratory fitness and preserved medial temporal lobe volume in Alzheimer disease. Alzheimer Dis Assoc Disord 23(3):188–197. https://doi.org/10.1097/WAD.0b013e31819cb8a2
Iaccarino L, Tammewar G, Ayakta N, Baker SL, Bejanin A, Boxer AL, Gorno-Tempini ML, Janabi M, Kramer JH, Lazaris A, Lockhart SN, Miller BL, Miller ZA, O'Neil JP, Ossenkoppele R, Rosen HJ, Schonhaut DR, Jagust WJ, Rabinovici GD (2018) Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's disease. NeuroImage Clinical 17:452–464. https://doi.org/10.1016/j.nicl.2017.09.016
Jabbarpour Z, Shahidi S, Saidijam M, Sarihi A, Hassanzadeh T, Esmaeili R (2014) Effect of tempol on the passive avoidance and novel object recognition task in diabetic rats. Brain Res Bull 101:51–56. https://doi.org/10.1016/j.brainresbull.2013.12.013
Jembrek MJ, Vlainic J (2015) GABA receptors: pharmacological potential and pitfalls. Curr Pharm Des 21(34):4943–4959
Jo S, Yarishkin O, Hwang YJ, Chun YE, Park M, Woo DH, Bae JY, Kim T, Lee J, Chun H, Park HJ, Lee DY, Hong J, Kim HY, Oh SJ, Park SJ, Lee H, Yoon BE, Kim Y (2014) GABA from reactive astrocytes impairs memory in mouse models of Alzheimer's disease. 20(8):886–896. https://doi.org/10.1038/nm.3639
Jones B (2013) Neurodegenerative disease: oxidative stress in cells near amyloid plaques linked to neuronal death. Nat Rev Neurol 9(6):300. https://doi.org/10.1038/nrneurol.2013.87
Kasza A, Penke B, Frank Z, Bozso Z, Szegedi V (2017) Studies for Improving a Rat Model of Alzheimer's Disease: Icv Administration of Well-Characterized beta-Amyloid 1–42 Oligomers Induce Dysfunction in Spatial Memory. 22(11). https://doi.org/10.3390/molecules22112007
Khodamoradi N, Komaki A, Salehi I, Shahidi S, Sarihi A (2015) Effect of vitamin E on lead exposure-induced learning and memory impairment in rats. Physiol Behav 144:90–94. https://doi.org/10.1016/j.physbeh.2015.03.015
Kirouac L, Rajic AJ, Cribbs DH, Padmanabhan J (2017) Activation of ras-erk signaling and gsk-3 by amyloid precursor protein and amyloid beta facilitates neurodegeneration in alzheimer's disease. 4(2). https://doi.org/10.1523/eneuro.0149-16.2017
Kirvell SL, Esiri M, Francis PT (2006) Down-regulation of vesicular glutamate transporters precedes cell loss and pathology in Alzheimer's disease. J Neurochem 98(3):939–950. https://doi.org/10.1111/j.1471-4159.2006.03935.x
Kleschevnikov AM, Belichenko PV, Faizi M, Jacobs LF, Htun K, Shamloo M, Mobley WC (2012) Deficits in cognition and synaptic plasticity in a mouse model of down syndrome ameliorated by GABAB receptor antagonists. J Neurosci 32(27):9217–9227. https://doi.org/10.1523/jneurosci.1673-12.2012
Komaki A, Shahidi S, Lashgari R, Haghparast A, Malakouti SM, Noorbakhsh SM (2007) Effects of GABAergic inhibition on neocortical long-term potentiation in the chronically prepared rat. Neurosci Lett 422(3):181–186. https://doi.org/10.1016/j.neulet.2007.06.017
Komaki A, Karimi SA, Salehi I, Sarihi A, Shahidi S, Zarei M (2015) The treatment combination of vitamins E and C and astaxanthin prevents high-fat diet induced memory deficits in rats. Pharmacol Biochem Behav 131:98–103. https://doi.org/10.1016/j.pbb.2015.02.008
Konermann A, Van Dyke T, Kantarci A, Jager A (2017) GABAB receptors as modulating target for inflammatory responses of the periodontal ligament. Cell Mol Neurobiol 37(6):1067–1076. https://doi.org/10.1007/s10571-016-0439-z
Lanctot KL, Herrmann N, Mazzotta P, Khan LR, Ingber N (2004) GABAergic function in Alzheimer's disease: evidence for dysfunction and potential as a therapeutic target for the treatment of behavioural and psychological symptoms of dementia. Can J Psychiatr 49(7):439–453. https://doi.org/10.1177/070674370404900705
Lashgari R, Khakpour-Taleghani B, Motamedi F, Shahidi S (2008) Effects of reversible inactivation of locus coeruleus on long-term potentiation in perforant path-DG synapses in rats. Neurobiol Learn Mem 90(2):309–316. https://doi.org/10.1016/j.nlm.2008.05.012
Lewis S (2017) Neurodegenerative disorders: amyloid clearance. Nat Rev Neurosci 18(8):455. https://doi.org/10.1038/nrn.2017.97
Li Y, Sun H, Chen Z, Xu H, Bu G, Zheng H (2016) Implications of GABAergic neurotransmission in Alzheimer's disease. Front Aging Neurosci 8:31. https://doi.org/10.3389/fnagi.2016.00031
Liu Q, Huang Y, Shen J, Steffensen S, Wu J (2012) Functional alpha7beta2 nicotinic acetylcholine receptors expressed in hippocampal interneurons exhibit high sensitivity to pathological level of amyloid beta peptides. BMC Neurosci 13:155. https://doi.org/10.1186/1471-2202-13-155
Liu QY, Wang CY, Cai ZL, Xu ST, Liu WX, Xiao P, Li CH (2014) Effects of intrahippocampal GABAB receptor antagonist treatment on the behavioral long-term potentiation and Y-maze learning performance. Neurobiol Learn Mem 114:26–31. https://doi.org/10.1016/j.nlm.2014.04.005
Liu Z, Zhou T, Ziegler AC, Dimitrion P, Zuo L (2017) Oxidative stress in neurodegenerative diseases: From molecular mechanisms to clinical applications. 2017:2525967. https://doi.org/10.1155/2017/2525967
Ma N, Abel T, Hernandez PJ (2009) Exchange protein activated by cAMP enhances long-term memory formation independent of protein kinase a. Learning & memory (Cold Spring Harbor, NY) 16(6):367–370. https://doi.org/10.1101/lm.1231009
Mahmoodi M, Shahidi S, Hasanein P (2011) Involvement of the ventral tegmental area in the inhibitory avoidance memory in rats. Physiol Behav 102(5):542–547. https://doi.org/10.1016/j.physbeh.2011.01.011
Makkar SR, Zhang SQ, Cranney J (2010) Behavioral and neural analysis of GABA in the acquisition, consolidation, reconsolidation, and extinction of fear memory. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 35(8):1625–1652. https://doi.org/10.1038/npp.2010.53
Mamelak M (2007) Alzheimer' s disease, oxidative stress and gammahydroxybutyrate. Neurobiol Aging 28(9):1340–1360. https://doi.org/10.1016/j.neurobiolaging.2006.06.008
Massone S, Vassallo I, Fiorino G, Castelnuovo M, Barbieri F, Borghi R, Tabaton M, Robello M, Gatta E, Russo C, Florio T, Dieci G, Cancedda R, Pagano A (2011) 17A, a novel non-coding RNA, regulates GABA B alternative splicing and signaling in response to inflammatory stimuli and in Alzheimer disease. Neurobiol Dis 41(2):308–317. https://doi.org/10.1016/j.nbd.2010.09.019
Mondadori C, Mobius HJ, Borkowski J (1996a) The GABAB receptor antagonist CGP 36,742 and the nootropic oxiracetam facilitate the formation of long-term memory. Behav Brain Res 77(1–2):223–225
Mondadori C, Moebius HJ, Zingg M (1996b) CGP 36,742, an orally active GABAB receptor antagonist, facilitates memory in a social recognition test in rats. Behav Brain Res 77(1–2):227–229
Nag S, Tang F, Yee BK (2001) Chronic intracerebroventricular exposure to beta-amyloid(1-40) impairs object recognition but does not affect spontaneous locomotor activity or sensorimotor gating in the rat. Exp Brain Res 136(1):93–100
Nava-Mesa MO, Jimenez-Diaz L, Yajeya J, Navarro-Lopez JD (2014) GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer's disease. Front Cell Neurosci 8:167. https://doi.org/10.3389/fncel.2014.00167
Nazari M, Komaki A, Salehi I, Sarihi A, Shahidi S, Komaki H, Ganji A (2016) Interactive effects of AM251 and baclofen on synaptic plasticity in the rat dentate gyrus. Brain Res 1651:53–60. https://doi.org/10.1016/j.brainres.2016.09.029
Nordberg A (2004) Functional studies of cholinergic activity in normal and Alzheimer disease states by imaging technique. Prog Brain Res 145:301–310. https://doi.org/10.1016/s0079-6123(03)45021-8
Paxinos G, Charles W (2017) The rat brain in stereotaxic coordinates, 6th edn. Academic Press, Amsterdam
Perfilova VN, Tiurenkov IN (2011) GABAC receptors: structure and functions. Eksp Klin Farmakol 74(1):45–49
Price KA, Varghese M, Sowa A, Yuk F, Brautigam H, Ehrlich ME, Dickstein DL (2014) Altered synaptic structure in the hippocampus in a mouse model of Alzheimer's disease with soluble amyloid-beta oligomers and no plaque pathology. Mol Neurodegener 9:41. https://doi.org/10.1186/1750-1326-9-41
Shahidi S, Komaki A, Mahmoodi M, Lashgari R (2008) The role of GABAergic transmission in the dentate gyrus on acquisition, consolidation and retrieval of an inhibitory avoidance learning and memory task in the rat. Brain Res 1204:87–93. https://doi.org/10.1016/j.brainres.2008.02.008
Shahidi S, Zargooshnia S, Asl SS, Komaki A, Sarihi A (2017) Influence of N-acetyl cysteine on beta-amyloid-induced Alzheimer's disease in a rat model: a behavioral and electrophysiological study. Brain Res Bull 131:142–149. https://doi.org/10.1016/j.brainresbull.2017.04.001
Shahidi S, Asl SS, Komaki A, Hashemi-Firouzi N (2018) The effect of chronic stimulation of serotonin receptor type 7 on recognition, passive avoidance memory, hippocampal long-term potentiation, and neuronal apoptosis in the amyloid beta protein treated rat. Psychopharmacology 235(5):1513–1525. https://doi.org/10.1007/s00213-018-4862-3
Sohanaki H, Baluchnejadmojarad T, Nikbakht F, Roghani M (2016) Pelargonidin improves memory deficit in amyloid beta25-35 rat model of Alzheimer's disease by inhibition of glial activation, cholinesterase, and oxidative stress. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 83:85–91. https://doi.org/10.1016/j.biopha.2016.06.021
Solas M, Puerta E, Ramirez MJ (2015) Treatment options in Alzheimer s disease: the GABA story. Curr Pharm Des 21(34):4960–4971
Staubli U, Scafidi J, Chun D (1999) GABAB receptor antagonism: facilitatory effects on memory parallel those on LTP induced by TBS but not HFS. J Neurosci 19(11):4609–4615
Sun B, Halabisky B, Zhou Y, Palop JJ, Yu G, Mucke L, Gan L (2009) Imbalance between GABAergic and glutamatergic transmission impairs adult neurogenesis in an animal model of Alzheimer's disease. Cell Stem Cell 5(6):624–633. https://doi.org/10.1016/j.stem.2009.10.003
Tahmasebi L, Komaki A, Karamian R, Shahidi S, Sarihi A, Salehi I, Nikkhah A (2015) The interactive role of cannabinoid and vanilloid systems in hippocampal synaptic plasticity in rats. Eur J Pharmacol 757:68–73. https://doi.org/10.1016/j.ejphar.2015.03.063
Villette V, Dutar P (2017) GABAergic microcircuits in Alzheimer's disease models. Curr Alzheimer Res 14(1):30–39
Waldmeier PC, Kaupmann K, Urwyler S (2008) Roles of GABAB receptor subtypes in presynaptic auto- and heteroreceptor function regulating GABA and glutamate release. Journal of neural transmission (Vienna, Austria: 1996) 115(10):1401–1411. https://doi.org/10.1007/s00702-008-0095-7
Wang B, Wang Z, Sun L, Yang L (2014) The amyloid precursor protein controls adult hippocampal neurogenesis through GABAergic interneurons. 34(40):13314–13325. https://doi.org/10.1523/jneurosci.2848-14.2014
White JH, McIllhinney RA, Wise A, Ciruela F, Chan WY, Emson PC, Billinton A, Marshall FH (2000) The GABAB receptor interacts directly with the related transcription factors CREB2 and ATFx. Proc Natl Acad Sci U S A 97(25):13967–13972. https://doi.org/10.1073/pnas.240452197
Yarishkin O, Lee J, Jo S, Hwang EM, Lee CJ (2015) Disinhibitory action of astrocytic GABA at the Perforant path to dentate gyrus granule neuron synapse reverses to inhibitory in Alzheimer's disease model. Experimental Neurobiology 24(3):211–218. https://doi.org/10.5607/en.2015.24.3.211
Zargooshnia S, Shahidi S, Ghahremanitamadon F, Nikkhah A, Mehdizadeh M, Soleimani Asl S (2015) The protective effect of Borago Officinalis extract on amyloid beta (25-35)-induced long term potentiation disruption in the dentate gyrus of male rats. Metab Brain Dis 30(1):151–156. https://doi.org/10.1007/s11011-014-9594-4
Zhang D, Mably AJ, Walsh DM, Rowan MJ (2017) Peripheral interventions enhancing brain glutamate homeostasis relieve amyloid beta- and TNFalpha-mediated synaptic plasticity disruption in the rat Hippocampus. Cerebral cortex (New York, NY: 1991) 27(7):3724–3735. https://doi.org/10.1093/cercor/bhw193
Acknowledgements
This research was supported by a grant (Grant number: 9505122862) from the Neurophysiology Research Centre of Hamadan University of Medical Sciences.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interest.
Rights and permissions
About this article
Cite this article
Almasi, A., Zarei, M., Raoufi, S. et al. Influence of hippocampal GABAB receptor inhibition on memory in rats with acute β-amyloid toxicity. Metab Brain Dis 33, 1859–1867 (2018). https://doi.org/10.1007/s11011-018-0292-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-018-0292-5